Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol., 14 July 2025

Sec. Inflammation Pharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1540873

Correction: Berberine ameliorates subarachnoid hemorrhage injury via induction of Sirtuin 1 and inhibiting HMGB1/Nf-κB pathway

This article is a correction to:

  1. Berberine Ameliorates Subarachnoid Hemorrhage Injury via Induction of Sirtuin 1 and Inhibiting HMGB1/Nf-κB Pathway

    1. Read original article
Xiang-Hua ZhangXiang-Hua Zhang1Lei PengLei Peng1Jing ZhangJing Zhang1Yi-Peng DongYi-Peng Dong1Cheng-Jun WangCheng-Jun Wang1Cang LiuCang Liu1Da-Yong Xia Da-Yong Xia2*Xiang-Sheng Zhang Xiang-Sheng Zhang1*
  • 1Department of Neurosurgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China
  • 2Department of Neurosurgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, China

A Correction on
Berberine ameliorates subarachnoid hemorrhage injury via induction of Sirtuin 1 and inhibiting HMGB1/Nf-κB pathway

by Zhang X-H, Peng L, Zhang J, Dong Y-P, Wang C-J, Liu C, Xia D-Y and Zhang X-S (2020). Front. Pharmacol. 11:1073. doi: 10.3389/fphar.2020.01073

There was a mistake in Figure 4A as published, concerning the NF-kB p65 protein band. It appears that the protein band was improperly cropped during the figure preparation. Furthermore, the Western blot image included in Figure 4A does not align with the complete Western blot image. The corrected Figure 4 appears below.

Figure 4
www.frontiersin.org

Figure 4. Effects of berberine treatment on SIRT1/HMGB1/TLR4/Myd88/Nf-κB signaling pathway after SAH. (A–F) Western blot assay (A) and quantification for the expression of SIRT1 (B), HMGB1 (C), TLR4 (D), Myd88 (E), and Nf-κB p65 (F) in the indicated groups. n = 6 per group. (G) Representative photomicrographs of immunofluorescence staining for Nf-κB p65. Bars represent the mean ± SD. *P < 0.05.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: subarachnoid hemorrhage, inflammation, berberine, HMGB1, Sirtuin 1

Citation: Zhang X-H, Peng L, Zhang J, Dong Y-P, Wang C-J, Liu C, Xia D-Y and Zhang X-S (2025) Correction: Berberine ameliorates subarachnoid hemorrhage injury via induction of Sirtuin 1 and inhibiting HMGB1/Nf-κB pathway. Front. Pharmacol. 16:1540873. doi: 10.3389/fphar.2025.1540873

Received: 06 December 2024; Accepted: 03 July 2025;
Published: 14 July 2025.

Edited and reviewed by:

Shu Wang, Beijing Tiantan Hospital, Capital Medical University, China

Copyright © 2025 Zhang, Peng, Zhang, Dong, Wang, Liu, Xia and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Da-Yong Xia, eGlhZHkxOTgxQDE2My5jb20=; Xiang-Sheng Zhang, emhhbmd4c3NwQDE2My5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.